Therapeutic potential of extracellular vesicles derived from cardiac progenitor cells in rodent models of chemotherapy-induced cardiomyopathy

BACKGROUND: Current treatments of chemotherapy-induced cardiomyopathy (CCM) are of limited efficacy. We assessed whether repeated intravenous injections of human extracellular vesicles from cardiac progenitor cells (EV-CPC) could represent a new therapeutic option and whether EV manufacturing accord...

Descripción completa

Detalles Bibliográficos
Autores principales: Desgres, Manon, Lima Correa, Bruna, Petrusca, Lorena, Autret, Gwennhael, Pezzana, Chloé, Marigny, Céline, Guillas, Chloé, Bellamy, Valérie, Vilar, José, Perier, Marie-Cécile, Dingli, Florent, Loew, Damarys, Humbert, Camille, Larghero, Jérôme, Churlaud, Guillaume, Renault, Nisa, Croisille, Pierre, Hagège, Albert, Silvestre, Jean-Sébastien, Menasché, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360184/
https://www.ncbi.nlm.nih.gov/pubmed/37485274
http://dx.doi.org/10.3389/fcvm.2023.1206279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360184/
https://www.ncbi.nlm.nih.gov/pubmed/37485274
http://dx.doi.org/10.3389/fcvm.2023.1206279

Ejemplares similares